1-4 of 4
Authors: Shirajul Islam
Journal Article
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort Open Access
Clinical Infectious Diseases, ciae601, https://doi.org/10.1093/cid/ciae601
Published: 10 December 2024
Journal Article
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs Open Access
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1307–1314, https://doi.org/10.1093/cid/ciac176
Published: 04 March 2022
Journal Article
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort Open Access
Clinical Infectious Diseases, Volume 75, Issue 6, 15 September 2022, Pages 1006–1013, https://doi.org/10.1093/cid/ciac019
Published: 13 January 2022
Journal Article
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis Free
Clinical Infectious Diseases, Volume 71, Issue 2, 15 July 2020, Pages 415–418, https://doi.org/10.1093/cid/ciz1084
Published: 02 November 2019
